FC11409B is a urea-sulfonamide carbonic anhydrase IX (CAIX) inhibitor; it inhibits proliferation and migration of breast cancer cell lines under both hypoxic (0.5% O₂) and normoxic (21% O₂) conditions; it also suppresses invasion of three-dimensional spheroids of breast cancer subtypes; FC11409B shows potential for research in breast cancer and ovarian cancer.